Persistent urticarial eruption in an asthmatic patient.
This case demonstrates the importance of recognizing urticarial vasculitis in patients with chronic urticarial eruptions. The salient points in history that point towards the diagnosis of urticarial vasculitis include the presence of painful urticarial lesions that last longer than 24 hours and that heal leaving residual pigmentation. In some cases the urticaria may evolve into palpable purpura. An associated systemic illness that may resemble systemic lupus erythematosus should also suggest the diagnosis, which is established by skin biopsy. Histopathology reveals a leukocytoclastic vasculitis involving postcapillary venules. When associated with systemic vasculitis, the urticaria is likely to be of the hypocomplementemic variety, with immunoglobulin and complement deposition on biopsies, and with serum complement studies demonstrating classical pathway activation, low C1q levels, and anti-C1q precipitins. A variety of agents have been used in the management of urticarial vasculitis, including aspirin, nonsteroidal anti-inflammatory agents, corticosteroids, colchicine, dapsone, hydroxychloroquine, and cytotoxic agents such as cyclophosphamide and azathioprine.
Mukkamala
R
R
Department of Internal Medicine, East Tennessee State University, Johnson City, USA.
Baban
N
N
Krishnaswamy
G
G
Smith
J K
JK
D000328:Adult; D001249:Asthma / Q000150:complications*; D001706:Biopsy; D003078:Colchicine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006074:Gout Suppressants / Q000627:therapeutic use; D006801:Humans; D007962:Leukocytes / Q000473:pathology; D012867:Skin / Q000473:pathology; D014581:Urticaria / Q000175:diagnosis* / Q000188:drug therapy; D014657:Vasculitis / Q000175:diagnosis* / Q000188:drug therapy
D006074:Gout Suppressants; D003078:Colchicine